Overview

• A federal judge in Los Angeles postponed Sangha’s trial four times before ordering it to begin Sept. 23.
• Sangha, 42, faces five counts of ketamine distribution, including one count resulting in death, and has pleaded not guilty.
• Prosecutors allege she marketed herself as a high-end supplier and sold Perry at least 25 vials days before his October 2023 overdose.
• Four co-defendants—Dr. Salvador Plasencia, Perry’s assistant, a friend and another doctor—have pleaded guilty and are awaiting sentencing.
• The case has spotlighted risks of off-label ketamine therapy for depression and prompted calls for tighter federal oversight.